Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings ... Ascendis also secured a $150 million funding deal with Royalty Pharma based on U.S. sales of Yorvipath.

Ratos AB Series B-2.46% kr11.01B ...

Spotify Technology S.A. 0.67% $94.1B ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...